RBT

The "RBT" company was established in 2011 for R&D projects in the field of innovative medicines. By combining research experience with successful practical implementation, "RBT" develops challenging projects in the area of biopharmaceuticals... In 2021, "Artgen Biotech" invested in the development of "RBT" biotechnology platform and creation a number of vaccine drugs against infectious diseases... CJSC "RBT" - the developer of own "Betusphere" platform for development of combined adjuvant systems for vaccines with a high safety profile